Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Chen, Gin Fu ^a   Sudhahar, Varadarajan ^a,b   Youn, Seock Won ^a   Das, Archita ^a   Cho, Jaehyung ^a   Kamiya, Tetsuro ^a   Urao, Norifumi ^a   McKinney, Ronald D ^a,b   Surenkhuu, Bayasgalan ^a   Hamakubo, Takao ^c   Iwanari, Hiroko ^c   Li, Senlin ^d   Christman, John W ^e   Shantikumar, Saran ^f   Angelini, Gianni D ^f,g   Emanueli, Costanza ^f,g   Ushio Fukai, Masuko ^a   Fukai, Tohru ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ATOX1 PROTEIN, HUMAN; ATP7A PROTEIN, HUMAN; CATION TRANSPORT PROTEIN; CELL ADHESION MOLECULE; METALLOCHAPERONE; NEUTROPHIL CYTOSOLIC FACTOR 1; PROTEIN LYSINE 6 OXIDASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HINDLIMB; HUMAN; ISCHEMIA; KNOCKOUT MOUSE; LEG; METABOLISM; MONOCYTE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CATION TRANSPORT PROTEINS; CELL ADHESION MOLECULES; CELL LINE; GENE EXPRESSION REGULATION; HINDLIMB; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; ISCHEMIA; LEG; METALLOCHAPERONES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN-LYSINE 6-OXIDASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84943267917     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14780     Document Type: Article

References (58)

1. Brewer, G. J. Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discov Today 10, 1103-1109, (2005)
2. Brewer, G. J. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation. J Cell Mol Med 7, 11-20 (2003).
3. Harris, E. D. A requirement for copper in angiogenesis. Nutr Rev 62, 60-64 (2004).
4. Goodman, V. L., Brewer, G. J., Merajver, S. D. Copper deficiency as an anti-cancer strategy. Endocr Relat Cancer 11, 255-263 (2004).
5. Wei, H., Zhang, W. J., McMillen, T. S., Leboeuf, R. C., Frei, B. Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 223, 306-313 (2012).
6. Daniel, K. G., Harbach, R. H., Guida, W. C., Dou, Q. P. Copper storage diseases: Menkes, Wilsons, and cancer. Front Biosci 9, 2652-2662 (2004).
7. Brewer, G. J. Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease. Exp Biol Med (Maywood) 226, 665-673 (2001).
8. Failla, M. L. Trace elements and host defense: recent advances and continuing challenges. J Nutr 133, 1443S-1447S (2003).
9. Percival, S. S. Copper and immunity. Am J Clin Nutr 67, 1064S-1068S (1998).
10. Pan, Q., Bao, L. W., Merajver, S. D. Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade. Mol Cancer Res 1, 701-706 (2003).
11. Pan, Q. et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res 62, 4854-4859 (2002).
12. Schuschke, D. A., Saari, J. T., Miller, F. N. Leukocyte-endothelial adhesion is impaired in the cremaster muscle microcirculation of the copper-deficient rat. Immunol Lett 76, 139-144 (2001).
13. Wei, H., Frei, B., Beckman, J. S., Zhang, W. J. Copper Chelation by Tetrathiomolybdate Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Vivo. Am J Physiol Heart Circ Physiol 301, H712-H720 (2011).
14. Kim, B. E., Nevitt, T., Thiele, D. J. Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol 4, 176-185 (2008).
15. Lutsenko, S., Barnes, N. L., Bartee, M. Y., Dmitriev, O. Y. Function and regulation of human copper-transporting ATPases. Physiol Rev 87, 1011-1046 (2007).
16. Hamza, I. et al. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc Natl Acad Sci USA 98, 6848-6852 (2001).
17. Itoh, S. et al. Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. J Biol Chem 283, 9157-9167 (2008).
18. Hamza, I., Schaefer, M., Klomp, L. W., Gitlin, J. D. Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis. Proc Natl Acad Sci USA 96, 13363-13368 (1999).
19. Ozumi, K. et al. Role of copper transport protein antioxidant 1 in angiotensin II-induced hypertension: a key regulator of extracellular superoxide dismutase. Hypertension 60, 476-486 (2012).
20. Alvarez, H. M. et al. Tetrathiomolybdate inhibits copper trafficking proteins through metal cluster formation. Science 327, 331-334 (2010).
21. Silvestre, J. S., Smadja, D. M., Levy, B. I. Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiol Rev 93, 1743-1802 (2013).
22. Zhang, H. et al. AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice. J Clin Invest 118, 3904-3916 (2008).
23. Tojo, T. et al. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111, 2347-2355 (2005).
24. Heil, M., Schaper, W. Insights into pathways of arteriogenesis. Curr Pharm Biotechnol 8, 35-42 (2007).
25. Barthel, S. R. et al. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci USA 106, 19491-19496 (2009).
26. Hidalgo, A. et al. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med 15, 384-391 (2009).
27. Cook-Mills, J. M., Marchese, M. E., Abdala-Valencia, H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal 15, 1607-1638 (2011).
28. Roebuck, K. A., Finnegan, A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66, 876-888 (1999).
29. Urao, N. et al. IQGAP1 is involved in post-ischemic neovascularization by regulating angiogenesis and macrophage infiltration. PLoS One 5, e13440 (2010).
30. Oshikawa, J. et al. Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS One 5, e10189 (2010).
31. Ushio-Fukai, M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res 71, 226-235 (2006).
32. Itoh, S. et al. Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1. Free Radic Biol Med 46, 95-104 (2009).
33. Osawa, T. et al. Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis. Br J Cancer 109, 2237-2247 (2013).
34. Baker, A. M. et al. Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res 73, 583-594 (2013).
35. Kohno, T. et al. Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury. Arterioscler Thromb Vasc Biol 33, 805-813 (2013).
36. Ashino, T. et al. Unexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migration. Circ Res 107, 787-799 (2010).
37. Raines, E. W. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15, 237-254 (2004).
38. Zhang, W. J., Frei, B. Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells. Free Radic Biol Med 34, 674-682 (2003).
39. McElwee, M. K., Song, M. O., Freedman, J. H. Copper activation of NF-kappaB signaling in HepG2 cells. J Mol Biol 393, 1013-1021 (2009).
40. Urao, N. et al. Critical role of endothelial hydrogen peroxide in post-ischemic neovascularization. PLoS One 8, e57618 (2013).
41. Tirziu, D. et al. Endothelial nuclear factor-kappaB-dependent regulation of arteriogenesis and branching. Circulation 126, 2589-2600 (2012).
42. Li, J. M. et al. Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ Res 90, 143-150 (2002).
43. Fan, J., Frey, R. S., Rahman, A., Malik, A. B. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factoralpha-induced NF-kappa B activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 277, 3404-3411 (2002).
44. Stokes, K. Y., Clanton, E. C., Russell, J. M., Ross, C. R., Granger, D. N. NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ Res 88, 499-505 (2001).
45. Chan, E. C. et al. Involvement of Nox2 NADPH oxidase in retinal neovascularization. Invest Ophthalmol Vis Sci 54, 7061-7067 (2013).
46. Craige, S. M. et al. NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 124, 731-740 (2011).
47. Garrido-Urbani, S. et al. Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARalpha mediated mechanism. PLoS One 6, e14665 (2011).
48. Schroder, K. et al. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110, 1217-1225 (2012).
49. Kim, I. et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276, 7614-7620 (2001).
50. Berasi, S. P., Xiu, M., Yee, A. S., Paulson, K. E. HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase. Mol Cell Biol 24, 3011-3024 (2004).
51. Li, S. L., Valente, A. J., Zhao, S. J., Clark, R. A. PU.1 is essential for p47(phox) promoter activity in myeloid cells. J Biol Chem 272, 17802-17809 (1997).
52. Kim, H. W., Lin, A., Guldberg, R. E., Ushio-Fukai, M., Fukai, T. Essential role of extracellular SOD in reparative neovascularization induced by hindlimb ischemia. Circ Res 101, 409-419 (2007).
53. Jiang, Y. et al. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med 204, 657-666 (2007).
54. Fukai, T., Ushio-Fukai, M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15, 1583-1606 (2011).
55. Urao, N., McKinney, R. D., Fukai, T., Ushio-Fukai, M. Nadph Oxidase 2 Regulates Bone Marrow Microenvironment Following Hindlimb Ischemia: Role in Reparative Mobilization of Progenitor Cells. Stem Cells 30, 923-934 (2012).
56. Sadikot, R. T. et al. p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol 172, 1801-1808 (2004).
57. Cho, Y. E., Basu, A., Dai, A., Heldak, M., Makino, A. Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice. Am J Physiol Cell Physiol 305, C1033-1040 (2013).
58. Saitoh, R. et al. Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus. J Immunol Methods 322, 104-117 (2007).